← Eichor
Study identifier: NCT07246356 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Feasibility and Efficacy of GTEP for Birth Trauma

Condition: PTSD (Childbirth-Related) · Psychological Wellbeing · Bonding  ·  Sponsor: University of Birmingham

PhaseNA
Planned participants10
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

This clinical study aims to evaluate the feasibility and initial efficacy of Group Traumatic Episode Protocol (GTEP) for reducing trauma symptoms (measured by the PCL-5 and City BiTS) for individuals following a traumatic birthing experience. A secondary aim is to evaluate the efficacy of GTEP in improving parental wellbeing (measured through the CORE-10) and parent-infant bonding (measured through the PBQ) following a traumatic birthing experience. Participants (those who have experienced a traumatic birthing experience) will complete the GTEP intervention, delivered online. They will be asked to complete outcome measures and give feedback on their experience of the group.

This description comes directly from the study's public registry record.

Talk to the study team

Grace E Rodgers, Study Chief Investigator  ·  +44 7817937825  ·  gxr327@student.bham.ac.uk

Rachel Strachan, Study Principal Investigator  ·  rachel.strachan1@nhs.net

Always discuss trial participation with your own doctor first.

Locations (1)

Black Country Healthcare NHS Foundation TrustWolverhampton, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07246356